The umbilical cord blood : controversies in medical law /

Since the therapeutic value of umbilical cord blood (UCB) stem cells was first recognised in the late 1980s, there has been a proliferation of both public and private UCB banks worldwide. However, the ability to utilise such a potentially valuable resource has provoked a number of controversies. In...

Full description

Saved in:
Bibliographic Details
Main Author: Devine, Karen
Format: Book
Language:English
Published: Milton Park, Abingdon, Oxon ; New York, NY : Routledge, 2017
Series:Biomedical law and ethics library
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000cam a2200000 i 4500
001 952470683
003 OCoLC
005 20190718110513.0
008 160624s2017 enk b 001 0 eng
010 |a 2016029647 
020 |a 9781138840881 
020 |a 1138840882 
040 |a DLC  |b eng  |e rda  |c DLC  |d YDXCP  |d BDX  |d BTCTA  |d YDX  |d LBRTY  |d OCLCO  |d CHVBK  |d OCLCO  |d OCLCQ  |d OCLCA  |d NLM  |d OCLCO  |d OCLCA  |d OCLCF  |d OCLCO  |d OCLCA 
042 |a pcc 
049 |a VLAM 
050 0 0 |a K3611.G46  |b D48 2017 
100 1 |a Devine, Karen 
245 1 4 |a The umbilical cord blood :  |b controversies in medical law /  |c Karen Devine 
260 |a Milton Park, Abingdon, Oxon ;  |a New York, NY :  |b Routledge,  |c 2017 
300 |a xvii, 205 pages ;  |c 24 cm 
490 1 |a Biomedical law and ethics library 
504 |a Includes bibliographical references and index 
505 0 |a Background to the controversies -- The risks of cord blood collection -- The rise of the cord blood industry -- Cord blood and the role of informed consent in law in the UK -- Cord blood and the standards of care in negligence in the UK -- Cord blood ownership 
520 |a Since the therapeutic value of umbilical cord blood (UCB) stem cells was first recognised in the late 1980s, there has been a proliferation of both public and private UCB banks worldwide. However, the ability to utilise such a potentially valuable resource has provoked a number of controversies. In a distinctly accessible style, this book unpacks the socio-legal implications of the UCB collection process and constructs a detailed analysis of the law and ethics that surrounds UCB banking in the UK, including ownership of the cells.--Back cover 
650 0 |a Biomedical engineering  |x Law and legislation 
650 0 |a Genetic engineering  |x Law and legislation 
650 0 |a Human experimentation in medicine  |x Law and legislation 
650 0 |a Human experimentation in medicine  |x Moral and ethical aspects 
650 0 |a Fetal blood  |x Transplantation  |x Moral and ethical aspects 
650 0 |a Stem cells  |x Transplantation  |x Moral and ethical aspects 
650 0 |a Blood banks  |x Law and legislation 
650 0 |a Fetal blood  |x Therapeutic use 
650 0 |a Hematopoietic stem cells 
650 0 |a Informed consent (Medical law) 
830 0 |a Biomedical law and ethics library 
907 |a .b2313170 
998 |a lower 
999 |c 125494 
852 |a Law Library  |b Lower Level  |h K3611.G46 D48 2017  |p 33940004426894